PRESS RELEASE published on 03/19/2025 at 07:30, 1 year 3 months ago Nicox Announces Last Patient Completes Final Visit in NCX 470 Phase 3b Whistler Glaucoma Trial Nicox completes final patient visits in Phase 3b Whistler Glaucoma Trial for NCX 470, with results expected May 2025. Denali trial in progress, results planned for Q3 2025 Clinical Development Nicox NCX 470 Phase 3b Glaucoma Trial
PRESS RELEASE published on 03/19/2025 at 07:30, 1 year 3 months ago Nicoxannonce que la visite finale du dernier patient a été effectuée dans l’étude de phase 3b Whistler sur le NCX 470 pour le glaucome Nicox annonce la fin de la visite du dernier patient dans l'étude de phase 3b Whistler sur le NCX 470 pour le glaucome. Résultats attendus en mai 2025 Étude Clinique Nicox NCX 470 Glaucome Phase 3b
BRIEF published on 01/28/2025 at 07:35, 1 year 5 months ago Nicox : Participation aux Grands Congrès en 2025 Investissement Ophtalmologie Congrès Nicox NCX 470
BRIEF published on 01/28/2025 at 07:35, 1 year 5 months ago Nicox: Participation in Major Congresses in 2025 Investment Ophthalmology Congress Nicox NCX 470
PRESS RELEASE published on 01/28/2025 at 07:30, 1 year 5 months ago Nicox : Présentation Scientifique et Participation aux Congrès du premier semestre 2025 Nicox annonce sa participation à des congrès internationaux en ophtalmologie et finance au premier semestre 2025, y compris l'AGS 2025 Congrès Annuel Finance Ophtalmologie Congrès Nicox AGS 2025
PRESS RELEASE published on 01/28/2025 at 07:30, 1 year 5 months ago Nicox Announces Scientific Presentation and Conference Attendance in H1 2025 Nicox to present at AGS 2025 Annual Meeting and attend key ophthalmology and financial conferences in H1 2025. Dr. Robert Fechtner to present NCX 470 analysis at AGS 2025 Conference Ophthalmology Nicox NCX 470 AGS 2025
BRIEF published on 01/22/2025 at 07:35, 1 year 5 months ago Nicox maintient son éligibilité au PEA-PME PEA-PME Investissement Euronext Ophtalmologie Nicox
BRIEF published on 01/22/2025 at 07:35, 1 year 5 months ago Nicox maintains its eligibility for the PEA-PME PEA-PME Euronext Investment Ophthalmology Nicox
PRESS RELEASE published on 01/22/2025 at 07:30, 1 year 5 months ago Nicox confirme son éligibilité au PEA-PME Nicox confirme son éligibilité au PEA-PME pour les 12 prochains mois, ouvrant la voie à l'investissement dans les petites et moyennes valeurs en ophtalmologie. Pour plus d'informations, consultez www.nicox.com PEA-PME Investissement Éligibilité Ophtalmologie Nicox
BRIEF published on 01/21/2025 at 07:35, 1 year 5 months ago Nicox : Résumé financier et activités du quatrième trimestre 2024 Résultats Financiers Trésorerie Nicox NCX 470 Quatrième Trimestre 2024
Published on 07/14/2026 at 22:30, 1 hour 55 minutes ago Hillcrest Energy Technologies Announces Board and Leadership Changes Following 2026 Annual General Meeting
Published on 07/14/2026 at 22:30, 1 hour 55 minutes ago Loop Industries Reports First Quarter Fiscal 2027 Results and Provides Update on Progress Towards Commercialization
Published on 07/14/2026 at 16:40, 7 hours 45 minutes ago AIAI Holdings' MediGuide Enters the State-of-the-Art Medicine Market With AI-Driven Innovation
Published on 07/14/2026 at 15:45, 8 hours 40 minutes ago Silver Storm Commences Hot Commissioning of the La Parrilla Sulphide Circuit, Amends the Samsung Prepayment Agreement, and Secures US$5 Million Loan from First Majestic
Published on 07/14/2026 at 15:15, 9 hours 10 minutes ago Gratomic Inc. Provides Corporate Update for Shareholders
Published on 07/14/2026 at 23:48, 36 minutes ago North Peak Announces Proposed Extension of Warrant Expiry Date
Published on 07/14/2026 at 19:14, 5 hours 11 minutes ago EQS-Adhoc: Nagarro SE: BaFin Enforcement Review of the 2022 Consolidated Financial Statements
Published on 07/14/2026 at 18:17, 6 hours 7 minutes ago EQS-Adhoc: Delivery Hero confirms advanced negotiations with Uber Technologies in respect to potential takeover offer
Published on 07/14/2026 at 17:51, 6 hours 33 minutes ago Aumann announces share buyback with an allotment ratio of approximately 6%
Published on 07/14/2026 at 17:30, 6 hours 55 minutes ago NABR: The U.S. Fish and Wildlife Service for the Second Time Rejects Activists' Petition to List Long-Tailed Macaque Monkeys Under the Endangered Species Act
Published on 07/13/2026 at 18:00, 1 day 6 hours ago CP Icade - Icade reprend 100% de la propriété de la Tour Eqho à la Défense
Published on 07/13/2026 at 18:00, 1 day 6 hours ago PR Icade - Icade regains full ownership of the Eqho Tower in La Défense
Published on 07/13/2026 at 18:00, 1 day 6 hours ago THERMADOR GROUPE : publication du chiffre d'affaires semestriel 2026
